Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Xiao‐Hong Cheng"'
Publikováno v:
Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
Abstract Background Sarcopenia is highly prevalent among patients with colorectal cancer (CRC). Computed tomography (CT)‐based assessment of low skeletal muscle index (SMI) is widely used for diagnosing sarcopenia. However, there are conflicting fi
Externí odkaz:
https://doaj.org/article/73d38e70196e44fa9238434c2c1a4752
Autor:
Ya-xin Li, Hong-fei Gao, Rui-bin Zhang, Kutlwano Gabana, Qing Chang, Gillian A. Gehring, Xiao-hong Cheng, Xiang-bing Zeng, Goran Ungar
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
A 3D‐ordered liquid crystal phase of regular right and left helically twisted columns self‐assembles from straight‐ and bent‐rod molecules. Here calculations indicate that, among four alternative models, the observed complex Fddd structure pr
Externí odkaz:
https://doaj.org/article/a14df41a45414cbd99fcef1c14790f4c
Autor:
Dan-Qian Chen, Gang Cao, Hua Chen, Christos P. Argyopoulos, Hui Yu, Wei Su, Lin Chen, David C. Samuels, Shougang Zhuang, George P. Bayliss, Shilin Zhao, Xiao-Yong Yu, Nosratola D. Vaziri, Ming Wang, Dan Liu, Jia-Rong Mao, Shi-Xing Ma, Jin Zhao, Yuan Zhang, You-Quan Shang, Huining Kang, Fei Ye, Xiao-Hong Cheng, Xiang-Ri Li, Li Zhang, Mei-Xia Meng, Yan Guo, Ying-Yong Zhao
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-15 (2019)
Accurate monitoring of chronic kidney disease (CKD) progression is essential for efficient disease management. Here Chen et al. identify five serum metabolites in patients with stage 1–5 CKD whose levels associate with disease progression, and find
Externí odkaz:
https://doaj.org/article/4a04997a433f49e4a807e4cf744638af
Autor:
Ying Zheng, Guang-Yan Cai, Li-Qun He, Hong-Li Lin, Xiao-Hong Cheng, Nian-Song Wang, Gui-Hua Jian, Xu-Sheng Liu, Yu-Ning Liu, Zhao-Hui Ni, Jing-Ai Fang, Han-Lu Ding, Wang Guo, Ya-Ni He, Li-Hua Wang, Ya-Ping Wang, Hong-Tao Yang, Zhi-Ming Ye, Ren-Huan Yu, Li-Juan Zhao, Wen-Hua Zhou, Wen-Ge Li, Hui-Juan Mao, Yong-Li Zhan, Zhao Hu, Chen Yao, Ri-Bao Wei, Xiang-Mei Chen
Publikováno v:
Chinese Medical Journal, Vol 130, Iss 20, Pp 2402-2409 (2017)
Background: Chronic kidney disease (CKD) with moderate-to-severe renal dysfunction usually exhibits an irreversible course, and available treatments for delaying the progression to end-stage renal disease are limited. This study aimed to assess the e
Externí odkaz:
https://doaj.org/article/89106fbf012e45b5acf3d74a66f9950a
Autor:
Hong-Rui Dong, Yan-Yan Wang, Xiao-Hong Cheng, Guo-Qing Wang, Li-Jun Sun, Hong Cheng, Yi-Pu Chen
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0156263 (2016)
BACKGROUND AND OBJECTIVES:The research work in the past years showed that detection of phospholipase A2 receptor (PLA2R) antigen and its dominant IgG4 autoantibody in glomerular deposits of patients with membranous nephropathy (MN) was useful for the
Externí odkaz:
https://doaj.org/article/704fee7bdbe545e089d88936857f8f11
Publikováno v:
In Defence Technology April 2021 17(2):609-616
Publikováno v:
In Defence Technology August 2020 16(4):893-899
Publikováno v:
In Defence Technology August 2019 15(4):655-665
Publikováno v:
Supramolecular Chemistry. 33:174-182
Bolaamphiphilies with D-A-D type ��-conjugated rigid cores composed by thiophenes as donors (D) and benzothiadiazole (BTD) as central acceptor (A) have been synthesised. Their self-assemblies and photophysical properties were investigated by pola
Autor:
Ming Chen, Jun-zhou Fu, Shuwei Duan, Rong Wang, Wenhu Liu, Xusheng Liu, Meng Liang, Wei Li, Ping Luo, Xiao-Hong Cheng, Xiangmei Chen, Li-qun Song, Ying Li, Jun Zhu, Zhiyong Guo, Ying Lu, Yun Li, Rong-shan Li, Li-Hua Wang, Niansong Wang, Yongli Zhan, Zhang Hao, Zhaohui Ni, Hongli Lin, Shan Lin, Qiang He, Jing-Ai Fang, Guangyan Cai, Qiao-ling Zhou, Ji-feng Sun, Ji-ning Gao, Changying Xing, Lu Ma, Jian Chen, Ai-ping Yin, Yueyi Deng, Li-qun He, Yani He, Jie Wu, Gengru Jiang, Hong-yu Chen, Hong-Tao Yang, Qing Zhu, Shi-ren Sun
Publikováno v:
Journal of Integrative Medicine. 19:111-119
Shenyankangfu Tablet (SYKFT) is a Chinese patent medicine that has been used widely to decrease proteinuria and the progression of chronic kidney disease.This trial compared the efficacy and safety of SYKFT, for the control of proteinuria in primary